Marbocyl P 20 mg Tablet

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

지금 구매하세요

Download 제품 특성 요약 (SPC)
29-09-2023

유효 성분:

Marbofloxacin

제공처:

Vetoquinol UK Ltd

ATC 코드:

QJ01MA93

INN (국제 이름):

Marbofloxacin

약제 형태:

Tablet

처방전 유형:

POM-V - Prescription Only Medicine – Veterinarian

치료 그룹:

Dogs

치료 영역:

Antimicrobial

승인 상태:

Authorized

승인 날짜:

2003-06-20

제품 특성 요약

                                Revised: September 2023
AN: 00690/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
MARBOCYL P 20 mg tablet
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient Marbofloxacin 20mg per tablet
FOR A FULL LIST OF EXCIPIENTS, SEE SECTION 6.1
3.
PHARMACEUTICAL FORM
Beige brown spotted round tablet
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
DOGS
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Marbofloxacin is indicated in the treatment of:

skin and soft tissue infections (skinfold pyoderma, impetigo,
folliculitis,
furunculosis, cellulitis) caused by susceptible strains of organisms.

urinary tract infections (UTI) associated or not with prostatitis
caused by
susceptible strains of organisms.

respiratory tract infections caused by susceptible strains of
organisms.
Revised: September 2023
AN: 00690/2023
Page 2 of 6
4.3
CONTRA-INDICATIONS
Marbofloxacin should not be used in dogs aged less than 12 months, or
less than 18 months for exceptionally large breeds of dogs, such as
Great
Danes, Briard, Bernese Bonvier and Mastiffs, with a longer growth
period.
Do not use in cases of hypersensitivity to fluoroquinolones or any of
the
excipients of the product.
Do not use in cases of resistance against quinolones since (almost)
complete cross-resistance exists against other fluoroquinolones.
Not suitable for infections resulting from strict anaerobes, yeast or
fungi.
Do not use in cats. For the treatment of this species, a 5 mg tablet
is
available.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Nil
4.5
SPECIAL PRECAUTIONS FOR USE
(I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The fluoroquinolones have been shown to induce erosion of articular
cartilage in juvenile dogs and care should be taken to dose accurately
especially in young animals.
The fluoroquinolones are also known for their potential neurological
side
effects. Cautious use is recommended in dogs and cats diagnosed as
suffering from epilepsy.
A low urinary pH could have an inhibitory effect on the activit
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림